期刊
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY
卷 21, 期 2, 页码 241-256出版社
ELSEVIER
DOI: 10.1016/j.bpa.2007.02.002
关键词
anti-platelet therapy; non-cardiac surgery; coronary stent thrombosis; surgical haemorrhage
Performing a surgical procedure on a patient undergoing anti-platelet therapy raises a dilemma: is it safer to withdraw the drugs and reduce the haemorrhagic risk, or to maintain them and reduce the risk of myocardial ischaemic events? Based on recent clinical data, this review concludes that the risk of coronary thrombosis on anti-platelet drugs withdrawal is much higher than the risk of surgical bleeding when maintaining them. In secondary prevention, aspirin is a lifelong therapy and should never be stopped. Clopidogrel is mandatory as long as the coronary stents are not fully endothelialized, which takes 6-24 weeks depending on the technique used, but might be required for a longer period.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据